Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Kimia Biosciences Ltd (KIMIABL) Share Price & Fundamentals

SegmentOfferingsAdvantages / MoatCustomersHigh-Margin AreasRevenue (₹ Cr.)Revenue %How We EarnPricing ModelGrowth DriversTop Brands
Pharmaceutical API ManufacturingManufacture and sale of bulk drug active pharmaceutical ingredients for anti-diabetic, anti-coagulant, antibiotic, antihistamine, and vitamin products.In-house raw material capability, GMP certification, experienced management, and strong client relationships.Pharmaceutical manufacturers (B2B) in India and overseas markets.Specialty APIs with complex synthesis such as Brivaracetam and Rivaroxaban.118100Revenue primarily through B2B sales contracts with pharmaceutical companies in India and export markets.Direct sales based on contracts; pricing influenced by volume and long-term agreements.Growing pharmaceutical demand, improved capacity utilization, better market access, and newer technology adoption.Brivaracetam, Dapagliflozin, Delafloxacin, Rivaroxaban, Apixaban

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions